Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma
- Autores
- Slat, Emily A.; Sponagel, Jasmin; Marpegan, Luciano; Simon, Tatiana; Kfoury, Najla; Kim, Albert; Binz, Andrea; Herzog, Erik D.; Rubin, Joshua B.
- Año de publicación
- 2017
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- The safety and efficacy of chemotherapeutics can vary as a function of the time of their delivery during the day. This study aimed to improve the treatment of glioblastoma (GBM), the most common brain cancer, by testing whether the efficacy of the DNA alkylator temozolomide (TMZ) varies with the time of its administration. We found cell-intrinsic, daily rhythms in both human and mouse GBM cells. Circadian time of treatment affected TMZ sensitivity of murine GBM tumor cells in vitro. The maximum TMZ-induced DNA damage response, activation of apoptosis, and growth inhibition occurred near the daily peak in expression of the core clock gene Bmal1. Deletion of Bmal1 (Arntl) abolished circadian rhythms in gene expression and TMZ-induced activation of apoptosis and growth inhibition. These data indicate that tumor cell-intrinsic circadian rhythms are common to GBM tumors and can regulate TMZ cytotoxicity. Optimization of GBM treatment by timing TMZ administration to daily rhythms should be evaluated in prospective clinical trials.
Fil: Slat, Emily A.. Washington University in St. Louis; Estados Unidos
Fil: Sponagel, Jasmin. Washington University in St. Louis; Estados Unidos
Fil: Marpegan, Luciano. Washington University in St. Louis; Estados Unidos. Universidad Nacional de Quilmes; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Simon, Tatiana. Washington University in St. Louis; Estados Unidos
Fil: Kfoury, Najla. Washington University in St. Louis; Estados Unidos
Fil: Kim, Albert. Washington University in St. Louis; Estados Unidos
Fil: Binz, Andrea. Washington University in St. Louis; Estados Unidos
Fil: Herzog, Erik D.. Washington University in St. Louis; Estados Unidos
Fil: Rubin, Joshua B.. Washington University in St. Louis; Estados Unidos - Materia
-
Bmal1 Gene
Dna Repair
Gbm
H2ax - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/42222
Ver los metadatos del registro completo
id |
CONICETDig_6fe9ff5c2be4fe4db9d3f73239b5bc2a |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/42222 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in GlioblastomaSlat, Emily A.Sponagel, JasminMarpegan, LucianoSimon, TatianaKfoury, NajlaKim, AlbertBinz, AndreaHerzog, Erik D.Rubin, Joshua B.Bmal1 GeneDna RepairGbmH2axhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1The safety and efficacy of chemotherapeutics can vary as a function of the time of their delivery during the day. This study aimed to improve the treatment of glioblastoma (GBM), the most common brain cancer, by testing whether the efficacy of the DNA alkylator temozolomide (TMZ) varies with the time of its administration. We found cell-intrinsic, daily rhythms in both human and mouse GBM cells. Circadian time of treatment affected TMZ sensitivity of murine GBM tumor cells in vitro. The maximum TMZ-induced DNA damage response, activation of apoptosis, and growth inhibition occurred near the daily peak in expression of the core clock gene Bmal1. Deletion of Bmal1 (Arntl) abolished circadian rhythms in gene expression and TMZ-induced activation of apoptosis and growth inhibition. These data indicate that tumor cell-intrinsic circadian rhythms are common to GBM tumors and can regulate TMZ cytotoxicity. Optimization of GBM treatment by timing TMZ administration to daily rhythms should be evaluated in prospective clinical trials.Fil: Slat, Emily A.. Washington University in St. Louis; Estados UnidosFil: Sponagel, Jasmin. Washington University in St. Louis; Estados UnidosFil: Marpegan, Luciano. Washington University in St. Louis; Estados Unidos. Universidad Nacional de Quilmes; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Simon, Tatiana. Washington University in St. Louis; Estados UnidosFil: Kfoury, Najla. Washington University in St. Louis; Estados UnidosFil: Kim, Albert. Washington University in St. Louis; Estados UnidosFil: Binz, Andrea. Washington University in St. Louis; Estados UnidosFil: Herzog, Erik D.. Washington University in St. Louis; Estados UnidosFil: Rubin, Joshua B.. Washington University in St. Louis; Estados UnidosSAGE Publications2017-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/42222Slat, Emily A.; Sponagel, Jasmin; Marpegan, Luciano; Simon, Tatiana; Kfoury, Najla; et al.; Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma; SAGE Publications; Journal of Biological Rhythms; 32; 2; 3-2017; 121-1290748-7304CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1177/0748730417696788info:eu-repo/semantics/altIdentifier/url/http://journals.sagepub.com/doi/10.1177/0748730417696788info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:11:47Zoai:ri.conicet.gov.ar:11336/42222instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:11:47.829CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma |
title |
Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma |
spellingShingle |
Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma Slat, Emily A. Bmal1 Gene Dna Repair Gbm H2ax |
title_short |
Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma |
title_full |
Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma |
title_fullStr |
Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma |
title_full_unstemmed |
Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma |
title_sort |
Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma |
dc.creator.none.fl_str_mv |
Slat, Emily A. Sponagel, Jasmin Marpegan, Luciano Simon, Tatiana Kfoury, Najla Kim, Albert Binz, Andrea Herzog, Erik D. Rubin, Joshua B. |
author |
Slat, Emily A. |
author_facet |
Slat, Emily A. Sponagel, Jasmin Marpegan, Luciano Simon, Tatiana Kfoury, Najla Kim, Albert Binz, Andrea Herzog, Erik D. Rubin, Joshua B. |
author_role |
author |
author2 |
Sponagel, Jasmin Marpegan, Luciano Simon, Tatiana Kfoury, Najla Kim, Albert Binz, Andrea Herzog, Erik D. Rubin, Joshua B. |
author2_role |
author author author author author author author author |
dc.subject.none.fl_str_mv |
Bmal1 Gene Dna Repair Gbm H2ax |
topic |
Bmal1 Gene Dna Repair Gbm H2ax |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
The safety and efficacy of chemotherapeutics can vary as a function of the time of their delivery during the day. This study aimed to improve the treatment of glioblastoma (GBM), the most common brain cancer, by testing whether the efficacy of the DNA alkylator temozolomide (TMZ) varies with the time of its administration. We found cell-intrinsic, daily rhythms in both human and mouse GBM cells. Circadian time of treatment affected TMZ sensitivity of murine GBM tumor cells in vitro. The maximum TMZ-induced DNA damage response, activation of apoptosis, and growth inhibition occurred near the daily peak in expression of the core clock gene Bmal1. Deletion of Bmal1 (Arntl) abolished circadian rhythms in gene expression and TMZ-induced activation of apoptosis and growth inhibition. These data indicate that tumor cell-intrinsic circadian rhythms are common to GBM tumors and can regulate TMZ cytotoxicity. Optimization of GBM treatment by timing TMZ administration to daily rhythms should be evaluated in prospective clinical trials. Fil: Slat, Emily A.. Washington University in St. Louis; Estados Unidos Fil: Sponagel, Jasmin. Washington University in St. Louis; Estados Unidos Fil: Marpegan, Luciano. Washington University in St. Louis; Estados Unidos. Universidad Nacional de Quilmes; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Simon, Tatiana. Washington University in St. Louis; Estados Unidos Fil: Kfoury, Najla. Washington University in St. Louis; Estados Unidos Fil: Kim, Albert. Washington University in St. Louis; Estados Unidos Fil: Binz, Andrea. Washington University in St. Louis; Estados Unidos Fil: Herzog, Erik D.. Washington University in St. Louis; Estados Unidos Fil: Rubin, Joshua B.. Washington University in St. Louis; Estados Unidos |
description |
The safety and efficacy of chemotherapeutics can vary as a function of the time of their delivery during the day. This study aimed to improve the treatment of glioblastoma (GBM), the most common brain cancer, by testing whether the efficacy of the DNA alkylator temozolomide (TMZ) varies with the time of its administration. We found cell-intrinsic, daily rhythms in both human and mouse GBM cells. Circadian time of treatment affected TMZ sensitivity of murine GBM tumor cells in vitro. The maximum TMZ-induced DNA damage response, activation of apoptosis, and growth inhibition occurred near the daily peak in expression of the core clock gene Bmal1. Deletion of Bmal1 (Arntl) abolished circadian rhythms in gene expression and TMZ-induced activation of apoptosis and growth inhibition. These data indicate that tumor cell-intrinsic circadian rhythms are common to GBM tumors and can regulate TMZ cytotoxicity. Optimization of GBM treatment by timing TMZ administration to daily rhythms should be evaluated in prospective clinical trials. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-03 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/42222 Slat, Emily A.; Sponagel, Jasmin; Marpegan, Luciano; Simon, Tatiana; Kfoury, Najla; et al.; Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma; SAGE Publications; Journal of Biological Rhythms; 32; 2; 3-2017; 121-129 0748-7304 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/42222 |
identifier_str_mv |
Slat, Emily A.; Sponagel, Jasmin; Marpegan, Luciano; Simon, Tatiana; Kfoury, Najla; et al.; Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma; SAGE Publications; Journal of Biological Rhythms; 32; 2; 3-2017; 121-129 0748-7304 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1177/0748730417696788 info:eu-repo/semantics/altIdentifier/url/http://journals.sagepub.com/doi/10.1177/0748730417696788 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
SAGE Publications |
publisher.none.fl_str_mv |
SAGE Publications |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844614020189913088 |
score |
13.070432 |